My Fawlty Wiring
Multiple Sclerosis Lives Here
Friday, October 23, 2015
Ocrelizumab, the new drug, goes after, what Dr. Edwards calls, misguided lymphocytes.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment